List view / Grid view

Haemophilia

 

Apitope raises €12 million in Series B funding

29 September 2015 | By Victoria White

The funds will enable Apitope to progress the clinical development of its innovative pipeline which includes therapies for Factor VIII intolerance in Haemophilia A patients...

Send this to a friend